116 related articles for article (PubMed ID: 38830802)
1. Coprococcus protects against high-fat diet-induced nonalcoholic fatty liver disease in mice.
Lu K; Zhou Y; He L; Li Y; Shahzad M; Li D
J Appl Microbiol; 2024 Jun; 135(6):. PubMed ID: 38830802
[TBL] [Abstract][Full Text] [Related]
2.
Mu J; Tan F; Zhou X; Zhao X
Food Funct; 2020 Oct; 11(10):8707-8723. PubMed ID: 32945305
[TBL] [Abstract][Full Text] [Related]
3.
Nguyen HT; Gu M; Werlinger P; Cho JH; Cheng J; Suh JW
Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362221
[TBL] [Abstract][Full Text] [Related]
4. Sex-specific maternal calcium requirements for the prevention of nonalcoholic fatty liver disease by altering the intestinal microbiota and lipid metabolism in the high-fat-diet-fed offspring mice.
Li P; Yan K; Chang X; Chen X; Wang R; Fan X; Tang T; Zhan D; Qi K
Gut Microbes; 2020 Nov; 11(6):1590-1607. PubMed ID: 32576050
[TBL] [Abstract][Full Text] [Related]
5. Pathogenic effects of Desulfovibrio in the gut on fatty liver in diet-induced obese mice and children with obesity.
Lin YC; Lin HF; Wu CC; Chen CL; Ni YH
J Gastroenterol; 2022 Nov; 57(11):913-925. PubMed ID: 35976494
[TBL] [Abstract][Full Text] [Related]
6. Bifidobacterium adolescentis and Lactobacillus rhamnosus alleviate non-alcoholic fatty liver disease induced by a high-fat, high-cholesterol diet through modulation of different gut microbiota-dependent pathways.
Wang G; Jiao T; Xu Y; Li D; Si Q; Hao J; Zhao J; Zhang H; Chen W
Food Funct; 2020 Jul; 11(7):6115-6127. PubMed ID: 32573567
[TBL] [Abstract][Full Text] [Related]
7. Microbial Intervention as a Novel Target in Treatment of Non-Alcoholic Fatty Liver Disease Progression.
Zhou Y; Zheng T; Chen H; Li Y; Huang H; Chen W; Du Y; He J; Li Y; Cao J; Nie Y; Zhou Y
Cell Physiol Biochem; 2018; 51(5):2123-2135. PubMed ID: 30522122
[TBL] [Abstract][Full Text] [Related]
8. Desulfovibrio vulgaris, a potent acetic acid-producing bacterium, attenuates nonalcoholic fatty liver disease in mice.
Hong Y; Sheng L; Zhong J; Tao X; Zhu W; Ma J; Yan J; Zhao A; Zheng X; Wu G; Li B; Han B; Ding K; Zheng N; Jia W; Li H
Gut Microbes; 2021; 13(1):1-20. PubMed ID: 34125646
[TBL] [Abstract][Full Text] [Related]
9. Ileal Bile Acid Transporter Inhibitor Improves Hepatic Steatosis by Ameliorating Gut Microbiota Dysbiosis in NAFLD Model Mice.
Matsui M; Fukunishi S; Nakano T; Ueno T; Higuchi K; Asai A
mBio; 2021 Aug; 12(4):e0115521. PubMed ID: 34225483
[TBL] [Abstract][Full Text] [Related]
10. Protective effects of Lactobacillus rhamnosus GG against dyslipidemia in high-fat diet-induced obese mice.
Kim B; Park KY; Ji Y; Park S; Holzapfel W; Hyun CK
Biochem Biophys Res Commun; 2016 Apr; 473(2):530-6. PubMed ID: 27018382
[TBL] [Abstract][Full Text] [Related]
11. Lactobacillus rhamnosus GG protects against non-alcoholic fatty liver disease in mice.
Ritze Y; Bárdos G; Claus A; Ehrmann V; Bergheim I; Schwiertz A; Bischoff SC
PLoS One; 2014; 9(1):e80169. PubMed ID: 24475018
[TBL] [Abstract][Full Text] [Related]
12. Lactobacillus plantarum NA136 ameliorates nonalcoholic fatty liver disease by modulating gut microbiota, improving intestinal barrier integrity, and attenuating inflammation.
Zhao Z; Chen L; Zhao Y; Wang C; Duan C; Yang G; Niu C; Li S
Appl Microbiol Biotechnol; 2020 Jun; 104(12):5273-5282. PubMed ID: 32335723
[TBL] [Abstract][Full Text] [Related]
13. Smilax China L. polysaccharide prevents HFD induced-NAFLD by regulating hepatic fat metabolism and gut microbiota.
Zhang W; Yu L; Yang Q; Zhang J; Wang W; Hu X; Li J; Zheng G
Phytomedicine; 2024 May; 127():155478. PubMed ID: 38452696
[TBL] [Abstract][Full Text] [Related]
14. Network pharmacology-based investigation to explore the effect and mechanism of Erchen decoction against the nonalcoholic fatty liver disease.
Liu H; Xu J; Li H; Zhang L; Xu P
Anat Rec (Hoboken); 2021 Nov; 304(11):2605-2619. PubMed ID: 34536264
[TBL] [Abstract][Full Text] [Related]
15. Hepatobiliary and pancreatic: Multi-donor fecal microbiota transplantation attenuated high-fat diet-induced hepatic steatosis in mice by remodeling the gut microbiota.
Shou D; Luo Q; Tang W; Cao C; Huang H; Chen H; Zhou Y
J Gastroenterol Hepatol; 2023 Dec; 38(12):2195-2205. PubMed ID: 37787118
[TBL] [Abstract][Full Text] [Related]
16. Ginsenoside Rg
Shi Y; Chen J; Qu D; Sun Q; Yu Y; Zhang H; Liu Z; Sha J; Sun Y
Nutrients; 2024 Mar; 16(6):. PubMed ID: 38542753
[TBL] [Abstract][Full Text] [Related]
17. Beneficial Effects of
Park EJ; Lee YS; Kim SM; Park GS; Lee YH; Jeong DY; Kang J; Lee HJ
Nutrients; 2020 Feb; 12(2):. PubMed ID: 32093158
[TBL] [Abstract][Full Text] [Related]
18. The Effect of Probiotics (MCP
Mohamad Nor MH; Ayob N; Mokhtar NM; Raja Ali RA; Tan GC; Wong Z; Shafiee NH; Wong YP; Mustangin M; Nawawi KNM
Nutrients; 2021 Sep; 13(9):. PubMed ID: 34579068
[TBL] [Abstract][Full Text] [Related]
19. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation.
Porras D; Nistal E; Martínez-Flórez S; Pisonero-Vaquero S; Olcoz JL; Jover R; González-Gallego J; García-Mediavilla MV; Sánchez-Campos S
Free Radic Biol Med; 2017 Jan; 102():188-202. PubMed ID: 27890642
[TBL] [Abstract][Full Text] [Related]
20. Combination of Probiotics and
Wang W; Xu AL; Li ZC; Li Y; Xu SF; Sang HC; Zhi F
Diabetes Metab J; 2020 Apr; 44(2):336-348. PubMed ID: 31950772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
